ANN SCHIEBER: Open Payments
NPI 1790123164 · LINCOLNSHIRE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,067 in 101 payments from 21 companies in 2025. Trend: 2023 $1,668 · 2024 $2,046 · 2025 $2,067
Food & beverage: $1,986Education: $81
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $283 |
| Janssen Biotech, Inc. | 12 | $266 |
| Arcutis Biotherapeutics, Inc. | 9 | $183 |
| Galderma Laboratories, L.P. | 19 | $183 |
| GENZYME CORPORATION | 6 | $165 |
| Regeneron Healthcare Solutions, Inc. | 4 | $160 |
| Novartis Pharmaceuticals Corporation | 5 | $141 |
| UCB, Inc. | 3 | $90 |
| Incyte Corporation | 3 | $79 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $74 |
Products named: DUPIXENT, TREMFYA, Zoryve, SKYRIZI, NEMLUVIO, Bimzelx, BOTOX, Rhapsido.
Industry payments across IL — which companies pay providers there.
